Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial

Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a backend or documentation update. The change reflects an internal update to the study record rather than modifications to visible study details.
    Difference
    0.0%
    Check dated 2026-07-25T11:35:29.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page shows a revised version label, updating the revision from v3.6.2 to v3.6.3. This indicates a minor site update rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-07-04T04:12:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision indicator updated from v3.6.0 to v3.6.2, signaling a small site update rather than a change to the study information.
    Difference
    0.0%
    Check dated 2026-06-27T01:48:14.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now includes a new line stating 'No longer looking for participants', indicating that recruitment for the study has ended. This informs readers that enrollment is closed and no new participants can join.
    Difference
    0.4%
    Check dated 2026-06-12T16:39:46.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the study record page.
    Difference
    0.1%
    Check dated 2026-06-05T12:33:46.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page’s revision label changed from v3.5.3 to v3.5.4, signaling a minor update to the page. There is no evident modification to the study details, eligibility criteria, or results in the provided context.
    Difference
    0.1%
    Check dated 2026-05-15T04:17:40.000Z thumbnail image

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.